Opendata, web and dolomites

NANOCANCER SIGNED

Getting new insights into the radio-sensitization effects of nanoparticles in photon and charged particle therapy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NANOCANCER project word cloud

Explore the words cloud of the NANOCANCER project. It provides you a very rough idea of what is the project "NANOCANCER" about.

biochemical    effect    amplified    realistic    photon    therapeutic    multidisciplinary    insights    breakthrough    dose    seems    interdisciplinary    cells    radiation    beams    microspectroscopy    shown    framework    molecular    cell    innovative    nano    radiotherapy    performing    mechanisms    damages    radio    vibrational    transform    atomic    substantially    simulation    fourier    deeper    glioma    complementary    charged    local    amplification    poor    enhancement    combining    purpose    underlying    enhanced    physical    action    biological    damage    gd    full    prognosis    nanoparticles    conventional    spectroscopy    killing    particle    nanometre    standard    effectiveness    monte    tumor    index    respect    diseases    light    first    nanocancer    sensitization    advantage    biology    np    time    cellular    clear    transport    au    employed    rt    macromolecules    carlo    therapy    ftir    strategy    radiobiology    interaction    tumour    sensitizers    infrared   

Project "NANOCANCER" data sheet

The following table provides information about the project.

Coordinator
CONSORCIO PARA LA CONSTRUCCION EQUIPAMIENTO Y EXPLOTACION DEL LABORATORIO DE LUZ SINCROTRON 

Organization address
address: CARRER DE LA LLUM 2-26
city: CERDANYOLA DEL VALLES BARCELONA
postcode: 8290
website: http://www.cells.es

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website https://www.cells.es/en/media/news/researchers-unveil-the-biochemical-effects-involved-in-nanoparticle-based-radiotherapy
 Total cost 158˙121 €
 EC max contribution 158˙121 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-SE
 Starting year 2017
 Duration (year-month-day) from 2017-10-30   to  2019-10-29

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CONSORCIO PARA LA CONSTRUCCION EQUIPAMIENTO Y EXPLOTACION DEL LABORATORIO DE LUZ SINCROTRON ES (CERDANYOLA DEL VALLES BARCELONA) coordinator 158˙121.00

Map

 Project objective

The use of high-atomic-number nanoparticles (NP) as tumour radio-sensitizers has been recently proposed as a breakthrough in radiotherapy (RT). Numerous biological studies have shown the enhanced effectiveness in tumor cell killing when NP were associated to photon RT and, more recently, to charged particle therapy. However, the mechanisms of action are not clear yet. In addition to the damage due to a possible local dose enhancement (physical effects), the interaction of NP with essential biological macromolecules could lead to changes in the cells (biochemical effects) leading to an amplified effect of the radiation. Within this framework, the main goal of the NANOCANCER project is to get deeper insights into the mechanisms underlying the amplification of radiation effects of NP. For this purpose, I will use a multidisciplinary strategy to evaluate both the biochemical and physical effects involved in these innovative nano-RT approaches. Vibrational spectroscopy (Fourier transform infrared, FTIR, microspectroscopy) will be employed for the first time to investigate the biochemical features in glioma cells combining two high-Z standard nanoparticles (Au and Gd) and charged particle beams. Physical effects will be also assessed by performing complementary Monte Carlo simulation of radiation transport, which will allow a realistic modelling of early biological damages induced by the radiation at the nanometre scale. This interdisciplinary proposal will be essential to better characterize the radio-sensitization effects of NP in glioma cells and, in addition, will bring light to the present charged particle therapy radiobiology, which seems to lead to substantially different tumour responses with respect to conventional RT at the cellular and molecular level. The knowledge of these biochemical features will help researchers to develop RT by taking full advantage of the underlying biology an enhance the therapeutic index of RT for diseases with poor prognosis.

 Publications

year authors and title journal last update
List of publications.
2019 I. Martínez-Rovira, O. Seksek, I. Yousef
A synchrotron-based infrared microspectroscopy study on the cellular response induced by gold nanoparticles combined with X-ray irradiations on F98 and U87-MG glioma cell lines
published pages: 6352-6364, ISSN: 0003-2654, DOI: 10.1039/c9an01109a
The Analyst 144/21 2019-12-16
2019 Immaculada Martínez-Rovira, Olivier Seksek, Josep Puxeu, Joan Gómez, Martin Kreuzer, Tanja Dučić, Maria Josep Ferreres, Manel Artigues, Ibraheem Yousef
Synchrotron-based infrared microspectroscopy study on the radiosensitization effects of Gd nanoparticles at megavoltage radiation energies
published pages: 5511-5520, ISSN: 0003-2654, DOI: 10.1039/C9AN00792J
The Analyst 144/18 2019-10-29

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NANOCANCER" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NANOCANCER" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

RAMBEA (2019)

Realistic Assessment of Historical Masonry Bridges under Extreme Environmental Actions

Read More  

IRF4 Degradation (2019)

Using a novel protein degradation approach to uncover IRF4-regulated genes in plasma cells

Read More  

PROSPER (2019)

Politics of Rulemaking, Orchestration of Standards, and Private Economic Regulations

Read More